Pin1 Enzyme Could Spur Development Of Personalized Cancer Medicines, According To Pintex Pharmaceuticals, Inc.; Highly Targeted Drugs Would Improve Treatment And Reduce Costs
10/19/2005 5:11:43 PM
More...
|
Pintex Pharmaceuticals, Inc. Acquires Worldwide Rights To Pin1 Related Technology From Max Planck Society; Will Enhance Pintex's Ability To Develop Cancer Therapies And Diagnostics
10/19/2005 5:10:47 PM
More...
|